Mitomycin C in Revision Endoscopic Dacryocystorhinostomy: A Prospective Randomized Study
- 1 November 2011
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology and Allergy
- Vol. 25 (6), 425-428
- https://doi.org/10.2500/ajra.2011.25.3676
Abstract
Background: Endoscopic dacryocystorhinostomy (EN-DCR) is an effective and safe procedure when treating saccal and postsaccal nasolacrimal duct obstruction. However, sometimes scarring of the rhinostomy site caused by fibrosis may occur, particularly in revision operations. The application of intraoperative mitomycin C (MMC), an antiproliferative agent, has been introduced as one possible technique to improve the outcome. We conducted a prospective, randomized study to evaluate if the use of MMC improves the success in endonasal revision DCR procedure.Methods: Thirty revision EN-DCR procedures were performed during 2004–2010. The patients were randomized into two study groups, according to whether the intraoperative MMC was used or not. The technique of EN-DCR procedure in both groups was the same, but in the MMC group, at the end of the procedure a piece of tampon soaked in MMC (0.4 mg/mL) was placed into the rhinostoma for 5 minutes. No silicone stents were inserted. The surgical outcome at the 6-month follow-up visit was considered successful if the lacrimal sac irrigation succeeded and if the patients’ symptoms were relieved.Results: The success rate after revision EN-DCR with MMC was 93% and without MMC was 60%. The overall success rate was 77%. The difference between the two groups was not statistically significant (p = 0.08). The relief of the symptoms between groups in both the Nasolacrimal Duct Obstruction Symptom Score and ocular symptoms was statistically significant (p = 0.007 and p = 0.02, respectively).Conclusion: The results of our study indicate that the application of intraoperative mitomycin C may improve the outcome in revision EN-DCR.Keywords
This publication has 37 references indexed in Scilit:
- Strong expression of HSP47 in metaplastic nasal mucosa may predict a poor outcome after primary endoscopic dacryocystorhinostomy: a prospective studyActa Ophthalmologica, 2011
- A comparison of outcomes between nonlaser endoscopic endonasal and external dacryocystorhinostomy: single-center experience and a review of British trendsAmerican Journal of Otolaryngology, 2010
- Mitomycin‐C‐augmented deep sclerectomy in patients with primary open‐angle glaucoma and exfoliation glaucoma: a 1‐year prospective studyActa Ophthalmologica, 2010
- Revision Endoscopic Dacryocystorhinostomy with Betamethasone Injection under Assisted Local AnaestheticOrbit, 2009
- Silicone Tubing is not Necessary after Primary Endoscopic Dacryocystorhinostomy: A Prospective Randomized StudyAmerican Journal of Rhinology, 2008
- External versus Endoscopic Dacryocystorhinostomy for Acquired Nasolacrimal Duct Obstruction in a Tertiary Referral CenterOphthalmology, 2005
- Intraoperative sponge 5-flourouracil to reduce postoperative scarring in strabismus surgeryJournal of American Association for Pediatric Ophthalmology and Strabismus, 1997
- Endoscopic Repair of Failed DacryocystorhinostomyOphthalmic Plastic & Reconstructive Surgery, 1990
- Intranasal Endoscopie Analysis of Dacrocystorhinostomy FailureOphthalmic Plastic & Reconstructive Surgery, 1988
- Endonasal DacryocystorhinostomyJAMA Otolaryngology–Head & Neck Surgery, 1974